These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 8497070)
1. Effect of linker insertion mutations in the human immunodeficiency virus type 1 gag gene on activation of viral protease expressed in bacteria. Luban J; Lee C; Goff SP J Virol; 1993 Jun; 67(6):3630-4. PubMed ID: 8497070 [TBL] [Abstract][Full Text] [Related]
2. Extended nucleocapsid protein is cleaved from the Gag-Pol precursor of human immunodeficiency virus type 1. Chen N; Morag A; Almog N; Blumenzweig I; Dreazin O; Kotler M J Gen Virol; 2001 Mar; 82(Pt 3):581-590. PubMed ID: 11172099 [TBL] [Abstract][Full Text] [Related]
3. Human immunodeficiency virus type 1 gag-protease fusion proteins are enzymatically active. Kotler M; Arad G; Hughes SH J Virol; 1992 Nov; 66(11):6781-3. PubMed ID: 1404618 [TBL] [Abstract][Full Text] [Related]
4. Proteolytic activity of human immunodeficiency virus Vpr- and Vpx-protease fusion proteins. Wu X; Liu H; Xiao H; Kappes JC Virology; 1996 May; 219(1):307-13. PubMed ID: 8623547 [TBL] [Abstract][Full Text] [Related]
5. Phenotypic characterization of insertion mutants of the human immunodeficiency virus type 1 Gag precursor expressed in recombinant baculovirus-infected cells. Chazal N; Carrière C; Gay B; Boulanger P J Virol; 1994 Jan; 68(1):111-22. PubMed ID: 8254720 [TBL] [Abstract][Full Text] [Related]
6. Proteolytic activity of novel human immunodeficiency virus type 1 proteinase proteins from a precursor with a blocking mutation at the N terminus of the PR domain. Zybarth G; Kräusslich HG; Partin K; Carter C J Virol; 1994 Jan; 68(1):240-50. PubMed ID: 8254734 [TBL] [Abstract][Full Text] [Related]
7. Altered gag polyprotein cleavage specificity of feline immunodeficiency virus/human immunodeficiency virus mutant proteases as demonstrated in a cell-based expression system. Lin YC; Brik A; de Parseval A; Tam K; Torbett BE; Wong CH; Elder JH J Virol; 2006 Aug; 80(16):7832-43. PubMed ID: 16873240 [TBL] [Abstract][Full Text] [Related]
8. Mutations in the protease gene of human immunodeficiency virus type 1 affect release and stability of virus particles. Park J; Morrow CD Virology; 1993 Jun; 194(2):843-50. PubMed ID: 8503189 [TBL] [Abstract][Full Text] [Related]
9. Altered Rous sarcoma virus Gag polyprotein processing and its effects on particle formation. Xiang Y; Ridky TW; Krishna NK; Leis J J Virol; 1997 Mar; 71(3):2083-91. PubMed ID: 9032340 [TBL] [Abstract][Full Text] [Related]
10. The nonmyristylated Pr160gag-pol polyprotein of human immunodeficiency virus type 1 interacts with Pr55gag and is incorporated into viruslike particles. Park J; Morrow CD J Virol; 1992 Nov; 66(11):6304-13. PubMed ID: 1383561 [TBL] [Abstract][Full Text] [Related]
11. Context surrounding processing sites is crucial in determining cleavage rate of a subset of processing sites in HIV-1 Gag and Gag-Pro-Pol polyprotein precursors by viral protease. Lee SK; Potempa M; Kolli M; Özen A; Schiffer CA; Swanstrom R J Biol Chem; 2012 Apr; 287(16):13279-90. PubMed ID: 22334652 [TBL] [Abstract][Full Text] [Related]
12. HIV-1 protease with leucine zipper fused at N-terminus exhibits enhanced linker amino acid-dependent activity. Yu FH; Wang CT Retrovirology; 2018 Apr; 15(1):32. PubMed ID: 29655366 [TBL] [Abstract][Full Text] [Related]
13. Human immunodeficiency virus type 1 MA deletion mutants expressed in baculovirus-infected cells: cis and trans effects on the Gag precursor assembly pathway. Chazal N; Gay B; Carrière C; Tournier J; Boulanger P J Virol; 1995 Jan; 69(1):365-75. PubMed ID: 7983731 [TBL] [Abstract][Full Text] [Related]
14. Analysis of protein expression and virus-like particle formation in mammalian cell lines stably expressing HIV-1 gag and env gene products with or without active HIV proteinase. Kräusslich HG; Ochsenbauer C; Traenckner AM; Mergener K; Fäcke M; Gelderblom HR; Bosch V Virology; 1993 Feb; 192(2):605-17. PubMed ID: 8421902 [TBL] [Abstract][Full Text] [Related]
15. Domains upstream of the protease (PR) in human immunodeficiency virus type 1 Gag-Pol influence PR autoprocessing. Zybarth G; Carter C J Virol; 1995 Jun; 69(6):3878-84. PubMed ID: 7745738 [TBL] [Abstract][Full Text] [Related]
16. The p6gag domain of human immunodeficiency virus type 1 is sufficient for the incorporation of Vpr into heterologous viral particles. Kondo E; Mammano F; Cohen EA; Göttlinger HG J Virol; 1995 May; 69(5):2759-64. PubMed ID: 7707498 [TBL] [Abstract][Full Text] [Related]
18. Expression and purification of active form of HIV-1 protease from E.coli. Wan M; Loh BN Biochem Mol Biol Int; 1995 Apr; 35(4):899-912. PubMed ID: 7627139 [TBL] [Abstract][Full Text] [Related]
19. Binding of human immunodeficiency virus type 1 (HIV-1) RNA to recombinant HIV-1 gag polyprotein. Luban J; Goff SP J Virol; 1991 Jun; 65(6):3203-12. PubMed ID: 2033671 [TBL] [Abstract][Full Text] [Related]
20. Natural variation in HIV-1 protease, Gag p7 and p6, and protease cleavage sites within gag/pol polyproteins: amino acid substitutions in the absence of protease inhibitors in mothers and children infected by human immunodeficiency virus type 1. Barrie KA; Perez EE; Lamers SL; Farmerie WG; Dunn BM; Sleasman JW; Goodenow MM Virology; 1996 May; 219(2):407-16. PubMed ID: 8638406 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]